These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 15536109

  • 1. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators.
    JAMA; 2004 Nov 10; 292(18):2227-36. PubMed ID: 15536109
    [Abstract] [Full Text] [Related]

  • 2. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
    Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT, Iyengar M, Anderson KM, Lukas MA, Bakris GL, GEMINI Investigators.
    J Cardiometab Syndr; 2008 Nov 10; 3(4):211-7. PubMed ID: 19040589
    [Abstract] [Full Text] [Related]

  • 3. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
    Wright JT, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.
    J Clin Hypertens (Greenwich); 2007 Nov 10; 9(11):842-9. PubMed ID: 17978591
    [Abstract] [Full Text] [Related]

  • 4. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS, Bakris GL, McGill JB.
    Diabetes Obes Metab; 2009 Mar 10; 11(3):234-8. PubMed ID: 18564334
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT, Waterhouse B, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators.
    Hypertension; 2005 Dec 10; 46(6):1309-15. PubMed ID: 16286578
    [Abstract] [Full Text] [Related]

  • 6. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
    Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V.
    J Diabetes Complications; 2008 Dec 10; 22(5):303-8. PubMed ID: 18413195
    [Abstract] [Full Text] [Related]

  • 7. Body weight changes with beta-blocker use: results from GEMINI.
    Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL, GEMINI Investigators.
    Am J Med; 2007 Jul 10; 120(7):610-5. PubMed ID: 17602935
    [Abstract] [Full Text] [Related]

  • 8. beta-blocker use and diabetes symptom score: results from the GEMINI study.
    McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS.
    Diabetes Obes Metab; 2007 May 10; 9(3):408-17. PubMed ID: 17391169
    [Abstract] [Full Text] [Related]

  • 9. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
    Bakris GL, Bell DS, Fonseca V, Katholi R, McGill J, Phillips R, Raskin P, Wright JT, Iyengar M, Holeslaw T, Anderson KM, GEMINI Investigators.
    J Diabetes Complications; 2005 May 10; 19(2):74-9. PubMed ID: 15745836
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
    Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT, Waterhouse B, Lukas MA, Anderson KM, GEMINI Investigators.
    Diabet Med; 2007 Jul 10; 24(7):759-63. PubMed ID: 17451422
    [Abstract] [Full Text] [Related]

  • 11. [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
    Frese T, Sandholzer H.
    Dtsch Med Wochenschr; 2007 Nov 10; 132(44):2330-1. PubMed ID: 17957597
    [Abstract] [Full Text] [Related]

  • 12. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
    Sica DA.
    J Clin Hypertens (Greenwich); 2005 Jan 10; 7(1):59-64. PubMed ID: 15655391
    [No Abstract] [Full Text] [Related]

  • 13. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ.
    Pharmacotherapy; 2006 Oct 10; 26(10):1491-500. PubMed ID: 16999659
    [Abstract] [Full Text] [Related]

  • 14. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 15. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM.
    Am J Hypertens; 2007 Jul 15; 20(7):777-83. PubMed ID: 17586413
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 17. Influence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabetics.
    Ehmer B, van der Does R, Rudorf J.
    Drugs; 1988 Aug 26; 36 Suppl 6():136-40. PubMed ID: 2908300
    [Abstract] [Full Text] [Related]

  • 18. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
    Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, Carvedilol Or Metoprolol European Trial Investigators.
    Lancet; 2003 Jul 05; 362(9377):7-13. PubMed ID: 12853193
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH.
    Clin Ther; 2012 Aug 05; 34(8):1735-50. PubMed ID: 22784975
    [Abstract] [Full Text] [Related]

  • 20. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.